Objective To estimate the proportion of patients with very severe osteoporosis (those covered by the reimbursement criteria of the Italian National Health Service) experiencing new vertebral and non-vertebral fragility fractures in the first 24 months of a new anti-osteoporosis treatment. Methods Prospective observational study in men and post-menopausal women (aged > 21 years) initiating anti-osteoporosis treatment for very severe osteoporosis. Eligibility was based on teriparatide (TPD) reimbursement criteria in Italy: Incident of vertebral or hip fracture during anti-resorptive treatment (minimum 1 year), or at least three prevalent severe vertebral fractures, or two prevalent severe vertebral fractures and a historical proximal hip frac...
Summary We estimated and characterized the imminent fracture risk (1–2 years) of high-risk fracture ...
Abstract None of the available osteoporosis therapies completely abolish the risk of fracture. Am...
Purpose: Literature data indicate that the proportion of patients with recent hip fracture who recei...
OBJECTIVES: To estimate the proportion of patients with very severe osteoporosis (those covered by ...
Objective To estimate the proportion of patients with very severe osteoporosis (those covered by the...
Objective Baseline characteristics of the population enrolled in the ISSO study, designed to evaluat...
OBJECTIVES: Baseline characteristics of the population enrolled in the ISSO study, designed to evalu...
None of the available osteoporosis therapies have been shown to completely abolish the risk of fract...
None of the available osteoporosis therapies have been shown to completely abolish the risk of fract...
Abstract None of the available osteoporosis therapies completely abolish the risk of fracture. Amon...
Summary: The patients’ adherence to osteoporosis treatments is low. In our study population a histor...
We estimated and characterized the imminent fracture risk (1-2 years) of high-risk fracture patients...
Summary We estimated and characterized the imminent fracture risk (1–2 years) of high-risk fracture ...
Abstract None of the available osteoporosis therapies completely abolish the risk of fracture. Am...
Purpose: Literature data indicate that the proportion of patients with recent hip fracture who recei...
OBJECTIVES: To estimate the proportion of patients with very severe osteoporosis (those covered by ...
Objective To estimate the proportion of patients with very severe osteoporosis (those covered by the...
Objective Baseline characteristics of the population enrolled in the ISSO study, designed to evaluat...
OBJECTIVES: Baseline characteristics of the population enrolled in the ISSO study, designed to evalu...
None of the available osteoporosis therapies have been shown to completely abolish the risk of fract...
None of the available osteoporosis therapies have been shown to completely abolish the risk of fract...
Abstract None of the available osteoporosis therapies completely abolish the risk of fracture. Amon...
Summary: The patients’ adherence to osteoporosis treatments is low. In our study population a histor...
We estimated and characterized the imminent fracture risk (1-2 years) of high-risk fracture patients...
Summary We estimated and characterized the imminent fracture risk (1–2 years) of high-risk fracture ...
Abstract None of the available osteoporosis therapies completely abolish the risk of fracture. Am...
Purpose: Literature data indicate that the proportion of patients with recent hip fracture who recei...